Related Experiment Video
Updated: May 26, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized
Tanja Sikjaer1, Lars Rejnmark, Jesper Skovhus Thomsen
1Department of Internal Medicine and Endocrinology, MEA, Aarhus University Hospital, Aarhus, Denmark. Tanja.sikjaer@gmail.com
Parathyroid hormone (PTH) therapy in hypoparathyroidism (hypoPT) alters bone structure, reducing thickness and density but increasing connectivity. This PTH substitution therapy impacts bone turnover and density differently across skeletal sites.
Area of Science:
- Endocrinology and Bone Metabolism
- Skeletal Biology and Histomorphometry
Background:
- Hypoparathyroidism (hypoPT) is associated with low bone turnover and high bone mineral density (BMD) despite standard treatments.
- Conventional management of hypoPT with calcium and vitamin D analogues does not fully address bone health complications.
Purpose of the Study:
- To investigate the effects of parathyroid hormone (PTH) substitution therapy on 3-dimensional bone structure in patients with hypoPT.
- To evaluate changes in trabecular and cortical bone microarchitecture and bone mineral density following PTH(1-84) treatment.
Main Methods:
- A 24-week randomized, placebo-controlled trial involving 62 patients with hypoPT, treated with either PTH(1-84) or placebo.
- Micro-computed tomography analysis of iliac crest bone biopsies to assess trabecular and cortical bone structure.
- Dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) to measure areal BMD (aBMD) and volumetric BMD (vBMD).
Main Results:
- PTH(1-84) treatment led to decreased trabecular thickness and bone tissue density, but increased trabecular connectivity density.
- Evidence of trabecular tunneling and increased Haversian canals in cortical bone was observed with PTH therapy.
- PTH treatment resulted in decreased hip aBMD and vBMD, but decreased lumbar spine aBMD with a significant increase in vBMD.
Conclusions:
- PTH(1-84) therapy significantly alters bone microarchitecture in hypoPT, suggesting a shift in bone remodeling dynamics.
- The differential effects on bone density at the hip and lumbar spine warrant further investigation into the long-term skeletal consequences of PTH treatment in hypoPT.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Skeleton and Calcium Homeostasis
Osteoclasts in Bone Remodeling
